Columna Capital

Columna Capital is a pan-European private equity firm specializing in lower mid-market investments across Western Europe. The firm focuses on sectors such as healthcare, animal health, insurance, and agri-food, targeting companies with revenues between €20 million and €100 million. Columna Capital typically invests up to €50 million in buyout and growth opportunities, emphasizing the identification of off-market deals and collaboration with management teams to drive long-term value creation.

The firm's investment strategy is centered on partnering with visionary entrepreneurs to build industry-leading companies. Columna Capital's portfolio includes companies like Santévet, a leader in pet health insurance; Physidia, a provider of home dialysis solutions; and Over, a provider of senior living solutions. The firm has a strong presence in Italy, with investments in companies such as Bianalisi, a clinical diagnostics provider, and MSA Group, a tech-enabled insurance claims management service.

Columna Capital's approach combines operational expertise with financial support to foster sustainable growth. The firm opened its Milan office in November 2024, reflecting its commitment to expanding its European footprint and supporting entrepreneur-led businesses. In June 2024, Columna Capital closed Fund III at €290 million, attracting institutional and family office investors from the US, UK, France, Switzerland, Italy, and South Africa, underscoring its strong position in the private equity market.